Delivery Order SPE2DB20D3304-SPE2DB25FW6D0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $3,003.00, with completion expected by September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $4,059.96. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the major pharmaceutical distributor. The contract has an ultimate completion date of September 15, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injections on June 4, 2025, with an ultimate completion date of June 5, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a single transaction for pharmaceutical supply under the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,619.90 on August 26, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement with an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $2,396.43 under a firm fixed price contract. This non-set-aside delivery order, with an ultimate completion date of May 6, 2025, is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively solicited delivery order by the Defense Logistics Agency on April 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injections. The contract, valued at $1,242.58 with a firm fixed price structure, is scheduled for completion by April 24, 2025, and will be fulfilled from the contractor's Pennsylvania location. This delivery order carries no set-aside designation and represents a single...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,076.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing federal contract portfolio...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on May 12, 2025. This is a firm fixed price, non-set-aside contract with a completion date of May 13, 2025, and performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW6D0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,130.04 on April 9, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors under firm fixed price terms. The contract is non-set-aside and competitively awarded, with an ultimate completion date of April 10, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order, which is issued as a child contract under a larger vehicle supporting federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA Troop Support Medical contract represents a critical component of the company's federal portfolio, facilitating flexible procurement of diabetes medications and other essential pharmaceuticals for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 4/9/25 |